|
Market Closed -
Nasdaq
21:00:00 28/08/2026 BST
|
5-day change | 1st Jan Change | ||
| 1.200 USD | -0.83% |
|
-1.64% | -48.50% |
| 08-12 | Spero Therapeutics, Inc., Q2 2026 Earnings Call, Aug 12, 2026 | |
| 08-12 | Spero Therapeutics, Inc. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2026 | CI |
| Market Cap | 69.88M 60.22M 56.46M 51.54M 97.09M 6.68B 97.4M 670M 261M 3.37B 262M 257M 11.18B | P/E 2024 |
-0.81x | P/E 2025 | 15.5x |
|---|---|---|---|---|---|
| Enterprise Value | 69.88M 60.22M 56.46M 51.54M 97.09M 6.68B 97.4M 670M 261M 3.37B 262M 257M 11.18B | EV / Sales 2024 |
1,170,430x | EV / Sales 2025 | - |
| Free-Float |
77.39% | Yield 2024 * |
-
| Yield 2025 | - |
Last Transcript : Spero Therapeutics, Inc.
| 1 day | -0.83% | ||
| 1 week | -1.64% | ||
| Current month | +2.56% | ||
| 3 months | -57.60% | ||
| 6 months | -45.21% | ||
| Current year | -48.50% |
| 1 week | 1.18 |  | 1.26 |
| 1 month | 1.12 | | 1.3 |
| Current year | 1.08 | | 3.08 |
| 1 year | 1.08 | | 3.08 |
| 3 years | 0.51 | | 3.22 |
| 5 years | 0.51 | | 19.87 |
| 10 years | 0.51 | | 23.64 |
| Manager | Title | Age | Since |
|---|---|---|---|
Esther Rajavelu
CEO | Chief Executive Officer | 47 | 09/01/2025 |
Timothy Keutzer
COO | Chief Operating Officer | 58 | 31/01/2023 |
Debra Zack
CTO | Chief Tech/Sci/R&D Officer | 69 | 26/07/2026 |
| Director | Title | Age | Since |
|---|---|---|---|
Milind Deshpande
CHM | Chairman | 69 | 31/12/2013 |
| Director/Board Member | 62 | 31/08/2015 | |
Frank Thomas
CHM | Chairman | 56 | 09/01/2025 |
| Date | Insider | Type | Main position | Quantity | % Market Cap. | |
|---|---|---|---|---|---|---|
| 03/08/26 | Free | Chief Technology Officer | 486,986 | 0.8411% | ||
| 04/05/26 | Sell | Chief Executive Officer | -25,240 | 0.0436% | ||
| 06/02/26 | Sell | Chief Executive Officer | 87,917 | 0.1560% |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | -0.83% | -1.64% | -42.03% | -16.67% | 69.88M | |
| -1.59% | -3.35% | +52.37% | +91.62% | 69.54B | |
| -1.34% | -0.75% | +48.21% | +92.23% | 64.97B | |
| +0.30% | -0.69% | +52.56% | +9.51% | 26.51B | |
| -2.35% | -5.75% | -12.90% | +436.87% | 25.89B | |
| -8.37% | -12.43% | +2.08% | -18.39% | 25.64B | |
| -0.96% | +10.36% | +283.06% | +429.04% | 20.22B | |
| -0.51% | +0.23% | +35.77% | -19.61% | 19.98B | |
| -1.91% | -4.37% | +13.28% | +557.93% | 15.69B | |
| -1.47% | +0.68% | +45.51% | +142.00% | 13.49B | |
| Average | -1.90% | -1.90% | +47.79% | +170.45% | 28.2B | |
| Weighted average by Cap. | -1.93% | -1.50% | +53.70% | +150.36% |
| 2024 | 2025 | |
|---|---|---|
| Net sales | 47.98M 41.34M 38.76M 35.38M 66.66M 4.59B 66.87M 460M 179M 2.31B 180M 176M 7.68B | 66.8M 57.56M 53.97M 49.27M 92.81M 6.38B 93.11M 640M 250M 3.22B 251M 245M 10.69B |
| Net income | -68.57M -59.08M -55.4M -50.57M -95.26M -6.55B -95.57M -657M -256M -3.31B -257M -252M -10.97B | 8.57M 7.39M 6.93M 6.32M 11.91M 819M 11.95M 82.17M 32.06M 414M 32.18M 31.48M 1.37B |
| Net Debt | - | - |
Employees
25
| Date | Price | Change | Volume |
|---|---|---|---|
| 28/08/26 | US$1.200 | -0.83% | 312,829 |
| 27/08/26 | US$1.210 | -0.82% | 538,487 |
| 26/08/26 | US$1.220 | -0.81% | 154,762 |
| 25/08/26 | US$1.230 | +1.23% | 645,540 |
| 24/08/26 | US$1.215 | -0.41% | 367,273 |
Sell
Buy
Mean consensus
HOLD
Number of Analysts
1
Last Close Price
1.200USD
Average target price
4.000USD
Spread / Average Target
+233.33%
Quarterly revenue - Rate of surprise
- Stock Market
- Stocks
- SPRO Stock
Select your edition
All financial news and data tailored to specific country editions
